How AI is applied across API Evangelist and APIs.io. Read my AI disclosure →
API Evangelist API Evangelist
Discovery
Learnings
Guidance
Toolbox
Alignment
API Evangelist LLC

Accutar Announces Achievement of Preclinical Development Milestone in Research Collaboration with Evommune on TLR7/8 Program

calendar_today November 2, 2026 person accutar domain accutar-biotechnology

CRANBURY, N.J., Nov. 2, 2026 - Accutar Biotechnology, Inc., a clinical-stage biotechnology company focused on artificial intelligence (AI)-empowered drug discovery, today announced the achievement of a preclinical development milestone in its multi-year, multi-target research collaboration with Evommune, Inc. (NYSE: EVMN), a clinical-stage biotechnology company developing innovative therapies that target key drivers of chronic inflammatory diseases.

open_in_new Read original post